Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gono Group is a healthcare and biotechnology company primarily focused on the development and distribution of diagnostic solutions and therapeutic support for infectious diseases, with a specific emphasis on sexually transmitted infections like gonorrhea. The company operates with a mission to improve public health outcomes through accessible testing and specialized medical services. While it maintains a presence in the broader healthcare market, its core expertise lies in addressing the rising challenges of antibiotic-resistant strains of Neisseria gonorrhoeae. Gono Group integrates clinical research with service delivery to provide comprehensive care pathways for patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GONO Group.